Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- International Institute of Molecular and Cell Biology in Warsaw
- RMIT University
- Uppsala University
- ;
- Duke University
- Karolinska Institutet
- Radboud University Medical Center (Radboudumc)
- Technical University of Munich
- University of Louisville
- University of Oslo
- ; University of Southampton
- ; University of Warwick
- Academic Europe
- CNRS
- Ilya Pharma
- Institute of Physical Chemistry, Polish Academy of Sciences
- Johannes Gutenberg University Mainz •
- Leibniz
- Linköping University
- Stockholm University
- TRON – Translationale Oncology Oncology at the University Medical Center of the Johannes Gutenberg University Mainz •
- Technical University of Denmark
- University Medical Centre Groningen (UMCG)
- University of Basel
- University of Florida
- University of Massachusetts Medical School
- University of Pittsburgh
- Université de Caen Normandie
- 18 more »
- « less
-
Field
-
at the Department of Biomedicine (“Cancer Immunology”) and PD Dr. Matter at the Department of Pathology are seeking a highly motivated PhD candidate with scientific interest in Cancer Immunology & Immunotherapy
-
. The Applied Immunology & Immunotherapy group is physically located at the Centre for Molecular Medicine, a translational medical centre, and the research focus is developing innovative ways to treat chronic
-
immunotherapies to fight diseases such as cancer. We are currently advertising a PhD position in this area (funded by an EPSRC DTP Studentship) in the Dept. of Chemistry at Warwick co-supervised by Dr Ann Dixon and
-
PhD Studentship - Extending the Chemical Space of mAb Based Cancer Treatment with DNA Nanostructures
the efficacy of immunotherapy drugs. Increasing numbers of immunotherapy drugs (such as monoclonal antibodies) have been incorporated into the up-front treatment of multiple types of cancers in the last 20 years
-
to impressive therapeutic effects, immunotherapies tend to take an increasingly important place in the treatment of many cancers such as lung or skin cancers. Immunotherapy consists of creating or strengthening a
-
urgent need to develop new treatment strategies. Immunotherapy has shown exciting promise for some solid tumours but has to date been ineffective for prostate cancer. Currently, it is unclear why prostate
-
a qualified Senior Researcher. This position will provide research training and experience in cellular immunology and tumor immunotherapy study. Previous training in immunology or biochemistry and
-
drugs account for a significant portion of newly developed medicines and are also used in in vivo diagnostics. This is also true for neurodegenerative diseases, where immunotherapy with monoclonal
-
. The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy. Gui P, Ben-Neji M, Belozertseva E, Dalenc F, Franchet C, Gilhodes J, Labrousse A, Bellard E
-
to study how the immune system can be harnessed to develop cancer immunotherapies. In particular, we are studying how oncolytic virotherapy can be used in synergy with immunotherapy to achieve optimal